Clinical trials
Phase 2 Lymphoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Celgene | 2 |
| Bayer | 1 |
| Children's Oncology Group | 1 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 1 |
| Hoffmann-La Roche | 1 |
| Maastricht University Medical Center | 1 |
| Meletios A. Dimopoulos | 1 |
| National Cancer Institute (NCI) | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 15 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Burkitt Lymphoma | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Dendritic Cell Sarcoma, Interdigitating | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Lymphoma, Follicular | 2 |
| Recurrence | 2 |
| Astrocytoma | 1 |
| Central Nervous System Neoplasms | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.